Infectious Diseases Therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Global Ganciclovir Market Research Report 2022By QYResearch Group "...... ent factors that aid the market growth.
Segment by Type
- Injection
- Oral
Segment by Application
- AIDS
- Tube transplant
- Malignant neoplasms
- CMV Infection
By......" | 08-Jul-2022 | $2900 | |
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Research Report 2022By QYResearch Group "...... e report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
- Daptomycin
- Linezolid
- Quinupristin/dalfopristin......" | 07-Jul-2022 | $2900 | |
Global Cefazolin Sodium Market Research Report 2022By QYResearch Group "...... pe Cefazolin Sodium market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %......" | 05-Jul-2022 | $2900 | |
Global Aspergillosis Drugs Market Research Report 2022By QYResearch Group "...... lth crisis, the Europe Aspergillosis Drugs market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while ......" | 04-Jul-2022 | $2900 | |
Chlamydia Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... view of the Chlamydia Infections (Infectious Disease) pipeline landscape.
Chlamydia is a sexually transmitted infection caused by a bacterium. Symptoms include burning feeling during urination, discharge from the penis or vagina, pain in......" | 30-Jun-2022 | $2000 | |
Resistant Pseudomonas aeruginosa Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... - Drugs In Development, 2022, provides an overview of the Resistant Pseudomonas aeruginosa Infections (Infectious Disease) pipeline landscape.
Pseudomonas aeruginosa has become an important cause of infection, especially in patients with......" | 30-Jun-2022 | $2000 | |
Tetanus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... tious Disease) pipeline landscape.
Tetanus is a serious illness caused by Clostridium bacteria. Signs and symptoms of tetanus include spasms and stiffness in jaw muscles, difficulty swallowing, stiffness of abdominal muscles, fever, swea......" | 30-Jun-2022 | $2000 | |
Schistosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... e Schistosomiasis (Infectious Disease) pipeline landscape.
Schistosomiasis is a type of infection caused by parasites that live in fresh water, such as rivers or lakes. Symptoms include a high temperature, headache, cough, a dark red, bl......" | 30-Jun-2022 | $2000 | |
Hepatitis C Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... tis C (Infectious Disease) pipeline landscape.
Hepatitis C is a contagious viral infection affecting the liver. It may spread on contact with infected blood. It may be a mild condition or may extend over a longer span of time leading to ......" | 30-Jun-2022 | $2500 | |
Herpes Zoster (Shingles) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... an overview of the Herpes Zoster (Shingles) (Infectious Disease) pipeline landscape.
Shingles (herpes zoster) is a painful, blistering skin rash. It is caused by the varicella-zoster virus. Symptoms may include fever and chills, headach......" | 30-Jun-2022 | $2000 | |
|